Suppr超能文献

金诺芬的药代动力学:人体单剂量研究

Pharmacokinetics of auranofin a single dose study in man.

作者信息

Benn H P, Schnier C, Seiler K U, Bauer E, Löffler H

机构信息

2nd Department of Internal Medicine, University of Kiel, West Germany.

出版信息

J Rheumatol. 1990 Apr;17(4):466-8.

PMID:2348424
Abstract

Three days after cholecystectomy 7 patients were given a single dose of auranofin (5 tablets Ridaura = 4.35 mg gold). Gold was detected in samples of blood, plasma, urine, bile and feces. The determinations were carried out using instrumental neutron activation analysis. The mean gold concentrations reached maximum in blood and plasma after 2 h and in urine and bile after 16 h. The mean terminal half-lives were 7.6 days (blood), 15 days (plasma) and 6.5 days (bile). Cumulative amounts of gold excreted in bile, urine, and feces were 1.6, 4 and 40%, respectively.

摘要

胆囊切除术后三天,给7名患者单次服用一剂金诺芬(5片瑞得 = 4.35毫克金)。在血液、血浆、尿液、胆汁和粪便样本中检测到了金。使用仪器中子活化分析法进行测定。血液和血浆中的平均金浓度在2小时后达到最高,尿液和胆汁中的平均金浓度在16小时后达到最高。平均终末半衰期分别为血液7.6天、血浆15天和胆汁6.5天。胆汁、尿液和粪便中排泄的金的累积量分别为1.6%、4%和40%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验